Shaorui Gu

887 total citations · 1 hit paper
16 papers, 527 citations indexed

About

Shaorui Gu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shaorui Gu has authored 16 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shaorui Gu's work include RNA modifications and cancer (8 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (4 papers). Shaorui Gu is often cited by papers focused on RNA modifications and cancer (8 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (4 papers). Shaorui Gu collaborates with scholars based in China. Shaorui Gu's co-authors include Yongxin Zhou, Chenglai Dong, Zhenchuan Liu, Kaiqing Wu, Yunlang She, Lei Li, Tingting Wang, Chang Chen, Tiancheng Lu and Wenli Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecular Cancer and Cell Cycle.

In The Last Decade

Shaorui Gu

16 papers receiving 523 citations

Hit Papers

N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-c... 2021 2026 2022 2024 2021 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer
    2021 267 citations Zhenchuan Liu, Tingting Wang et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shaorui Gu China 10 425 271 84 66 55 16 527
Chenglai Dong China 7 401 0.9× 260 1.0× 79 0.9× 53 0.8× 51 0.9× 10 482
Juhong Wang China 12 419 1.0× 280 1.0× 83 1.0× 50 0.8× 35 0.6× 17 507
Ye‐Lin Liang China 12 410 1.0× 304 1.1× 104 1.2× 54 0.8× 78 1.4× 21 541
Cuiling Zeng China 9 443 1.0× 280 1.0× 76 0.9× 69 1.0× 48 0.9× 13 527
Tianliang Xia China 12 241 0.6× 125 0.5× 119 1.4× 81 1.2× 44 0.8× 21 366
Zuoming Xu China 12 387 0.9× 313 1.2× 59 0.7× 53 0.8× 73 1.3× 20 486
Zhe Xuan China 9 525 1.2× 431 1.6× 58 0.7× 56 0.8× 85 1.5× 17 653
Sheng‐Yan Huang China 11 245 0.6× 123 0.5× 53 0.6× 58 0.9× 44 0.8× 21 339
Yihang Guo China 13 347 0.8× 263 1.0× 53 0.6× 46 0.7× 24 0.4× 31 444
Xiaozhi Lv China 12 387 0.9× 276 1.0× 97 1.2× 66 1.0× 26 0.5× 38 515

Countries citing papers authored by Shaorui Gu

Since Specialization
Citations

This map shows the geographic impact of Shaorui Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaorui Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaorui Gu more than expected).

Fields of papers citing papers by Shaorui Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaorui Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaorui Gu. The network helps show where Shaorui Gu may publish in the future.

Co-authorship network of co-authors of Shaorui Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Shaorui Gu. A scholar is included among the top collaborators of Shaorui Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaorui Gu. Shaorui Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Gu, Shaorui, et al.. (2024). Identification of important genes related to anoikis in acute myocardial infarction. Journal of Cellular and Molecular Medicine. 28(8). e18264–e18264. 4 indexed citations
2.
Gu, Shaorui, et al.. (2024). NEK2 promotes the migration, invasion, proliferation of ESCC and mediates ESCC immunotherapy. Heliyon. 10(9). e29682–e29682. 6 indexed citations
3.
Gu, Shaorui, et al.. (2023). The Underlying Mechanism Involved in Gefitinib Resistance and Corresponding Experiment Validation in Lung Cancer. Mediators of Inflammation. 2023. 1–27. 2 indexed citations
4.
Wang, Mengying, et al.. (2023). A Machine Learning-Based Classification of Immunogenic Cell Death Regulators and Characterisation of Immune Microenvironment in Acute Ischemic Stroke. International Journal of Clinical Practice. 2023. 1–13. 2 indexed citations
5.
Li, Lei, Yan Gao, Zhenchuan Liu, et al.. (2022). GDF11 alleviates neointimal hyperplasia in a rat model of artery injury by regulating endothelial NLRP3 inflammasome activation and rapid re-endothelialization. Journal of Translational Medicine. 20(1). 28–28. 11 indexed citations
6.
Gu, Shaorui, et al.. (2022). Effects of Preserving the Pulmonary Vagus Nerve Branches on Cough After Pneumonectomy During Video-Assisted Thoracic Surgery. Frontiers in Oncology. 12. 837413–837413. 9 indexed citations
7.
Dong, Chenglai, et al.. (2022). PTBP3 mediates TGF-β-induced EMT and metastasis of lung adenocarcinoma. Cell Cycle. 21(13). 1406–1421. 16 indexed citations
8.
9.
Gu, Shaorui, Tiancheng Lu, Chenglai Dong, et al.. (2022). Feasibility evaluation of the transapical saddle‐shaped valved stent for transcatheter mitral valve implantation. Journal of Cardiac Surgery. 37(6). 1537–1543. 1 indexed citations
10.
Liu, Zhenchuan, Tingting Wang, Yunlang She, et al.. (2021). N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. Molecular Cancer. 20(1). 105–105. 267 indexed citations breakdown →
11.
Liu, Zhenchuan, et al.. (2021). CircRNA-DOPEY2 enhances the chemosensitivity of esophageal cancer cells by inhibiting CPEB4-mediated Mcl-1 translation. Journal of Experimental & Clinical Cancer Research. 40(1). 361–361. 43 indexed citations
12.
Gu, Shaorui, Haitao Huang, Chongjun Zhong, et al.. (2021). Upregulation of glucosamine‑phosphate N‑acetyltransferase 1 is a promising diagnostic and predictive indicator for poor survival in patients with lung adenocarcinoma. Oncology Letters. 21(6). 488–488. 10 indexed citations
13.
14.
Huang, Haitao, Shaorui Gu, Zhenchuan Liu, et al.. (2020). Long Noncoding RNA FAM225A Promotes Esophageal Squamous Cell Carcinoma Development and Progression via Sponging MicroRNA-197-5p and Upregulating NONO. Journal of Cancer. 12(4). 1073–1084. 10 indexed citations
15.
Liu, Zhenchuan, Shaorui Gu, Tiancheng Lu, et al.. (2020). IFI6 depletion inhibits esophageal squamous cell carcinoma progression through reactive oxygen species accumulation via mitochondrial dysfunction and endoplasmic reticulum stress. Journal of Experimental & Clinical Cancer Research. 39(1). 144–144. 69 indexed citations
16.
Gu, Shaorui, et al.. (2019). MiR-92a regulates endothelial progenitor cells (EPCs) by targeting GDF11 via activate SMAD2/3/FAK/Akt/eNOS pathway. Annals of Translational Medicine. 7(20). 563–563. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chenglai Dong Breakdown of academic impact, for papers by Juhong Wang Breakdown of academic impact, for papers by Ye‐Lin Liang Breakdown of academic impact, for papers by Cuiling Zeng Breakdown of academic impact, for papers by Tianliang Xia Breakdown of academic impact, for papers by Zuoming Xu Breakdown of academic impact, for papers by Zhe Xuan Breakdown of academic impact, for papers by Sheng‐Yan Huang Breakdown of academic impact, for papers by Yihang Guo Breakdown of academic impact, for papers by Xiaozhi Lv
Rankless by CCL
2026